Publication | Closed Access
A randomized phase III study of irinotecan and cisplatin (CP) versus etoposide and cisplatin (EP) in extensive-disease small-cell lung cancer (ED-SCLC): Japan Clinical Oncology Group Study (JCOG 9511)
71
Citations
0
References
2000
Year
MedicinePathologyBronchial NeoplasmMolecular OncologyJcog 9511Cancer TreatmentOncologyRadiation OncologyLung CancerCancer ResearchVersus Etoposide
No additional data available for this publication yet. Check back later!